AI-powered Portable MRI Abnormality Detection
Launched by KING'S COLLEGE HOSPITAL NHS TRUST · Jan 27, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new type of MRI scanner that uses artificial intelligence (AI) to quickly check brain scans for any problems, especially for patients with head injuries. Traditional MRI scans can be expensive and take a long time to get, so this study aims to see if a smaller, more affordable portable MRI scanner can help doctors find issues faster and improve care for patients.
If you're an adult over 18 years old and are already scheduled for a standard brain MRI, you may be eligible to participate. This would involve having an additional scan with the portable MRI, which takes about an hour. The AI will analyze the scans and compare its findings with those from expert radiologists. By the end of the study, we hope to show whether this new portable MRI technology can be used in hospitals and clinics, making brain scans easier to access and reducing waiting times for patients. The study is funded by the Medical Research Council and has received approval from ethical committees in the UK.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults ≥18 years old. Undergoing standard brain MRI including T2-weighted sequences.
- Exclusion Criteria:
- • Contraindications to MRI (e.g. pacemaker, pregnancy). Poor quality MRI scans without a neuroradiology report.
About King's College Hospital Nhs Trust
King's College Hospital NHS Trust is a leading healthcare institution in the United Kingdom, renowned for its commitment to providing high-quality patient care and advancing medical research. With a strong emphasis on clinical excellence, the Trust supports a wide range of clinical trials across various specialties, leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals. By fostering innovation and collaboration, King's College Hospital NHS Trust aims to enhance treatment options and improve outcomes for patients, while contributing to the global body of medical knowledge through rigorous scientific investigation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Thomas Booth, Dr
Principal Investigator
King's College London & King's College Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported